More US Kids Under 12 Treated for Obesity with Off-Label Weight Loss Drugs, 310 Times Higher Now Than in 2019
A new study published by NYU Langone reveals that GLP-1 receptor agonist prescriptions given to U.S. children aged 8 to 11 were 310 times higher in June 2026 than in … Read More